The current body of evidence concerning the involvement of β3-AR in obesity remains inconclusive, leaving uncertainty about whether mutations in β3-AR contribute to the pathogenesis of obesity or aid in its management by activating it. The gene discussed is ADRB3; the disease is obesity disorder.